Unveiling 8 Analyst Insights On Progyny
Portfolio Pulse from Benzinga Insights
Eight analysts have recently published ratings on Progyny (NASDAQ:PGNY), showing a range of perspectives from bullish to bearish. The average 12-month price target has decreased from $43.71 to $34.75, with a high estimate of $48.00 and a low estimate of $24.00. Analysts have adjusted their ratings and price targets based on recent market conditions and company performance.
August 07, 2024 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Eight analysts have provided mixed ratings on Progyny (NASDAQ:PGNY) over the past three months. The average 12-month price target has decreased from $43.71 to $34.75, reflecting a 20.5% decline. Analysts have adjusted their ratings and price targets based on recent market conditions and company performance.
The mixed analyst ratings and the significant decrease in the average 12-month price target indicate uncertainty about Progyny's short-term performance. While some analysts remain bullish, others have lowered their price targets, reflecting concerns about the company's recent market performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100